BamSEC and AlphaSense Join Forces
Learn More

Rein Therapeutics Inc. – Transcripts

NASDAQ: RNTX    
Share price (8/5/26): $0.71    
Market cap (8/5/26): $61.1 million
Search in Documents
Key Exhibits
External Links

Transcripts

CY 2026
Other Revised 07/20/26 Rein Therapeutics Inc. - Shareholder/Analyst Call 07/20/26
CY 2024
Other Revised 11/13/24 Aileron Therapeutics, Inc. - Special Call 11/13/24
Other Revised 08/20/24 Aileron Therapeutics, Inc. - Shareholder/Analyst Call 08/20/24
Other Revised 05/01/24 Aileron Therapeutics, Inc. - Special Call 05/01/24
Other Revised 02/16/24 Aileron Therapeutics, Inc. - Special Call 02/15/24
CY 2023
M&A Revised 10/31/23 Aileron Therapeutics, Inc., Lung Therapeutics, Inc. - M&A Call 10/31/23
CY 2022
Other Revised 06/29/22 Aileron Therapeutics, Inc. - Special Call 06/29/22
Other Revised 06/15/22 Aileron Therapeutics, Inc. - Shareholder/Analyst Call 06/15/22
Other Revised 05/19/22 Aileron Therapeutics, Inc. - Special Call 05/19/22
CY 2021
Other Revised 06/15/21 Aileron Therapeutics, Inc. - Shareholder/Analyst Call 06/15/21
CY 2020
Other Revised 10/26/20 Aileron Therapeutics, Inc. - Special Call 10/26/20
Other Revised 06/17/20 Aileron Therapeutics, Inc. - Shareholder/Analyst Call 06/17/20
Other Revised 06/01/20 Aileron Therapeutics, Inc. - Special Call 06/01/20
CY 2019
Earnings Revised 11/07/19 Aileron Therapeutics, Inc., Q3 2019 Earnings Call, Nov 07, 2019 11/07/19